Your browser doesn't support javascript.
loading
Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden.
Marking, Ulrika; Bladh, Oscar; Aguilera, Katherina; Yang, Yiqiu; Greilert Norin, Nina; Blom, Kim; Hober, Sophia; Klingström, Jonas; Havervall, Sebastian; Åberg, Mikael; Sheward, Daniel J; Thålin, Charlotte.
Afiliación
  • Marking U; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden; Public Health Agency of Sweden, Sweden.
  • Bladh O; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden.
  • Aguilera K; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden.
  • Yang Y; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Greilert Norin N; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden.
  • Blom K; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden; Public Health Agency of Sweden, Sweden.
  • Hober S; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden; Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Klingström J; Public Health Agency of Sweden, Sweden; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Havervall S; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden; Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Åberg M; Department of Medical Sciences, Clinical Chemistry and SciLifeLab Affinity Proteomics, Uppsala University, Uppsala, Sweden.
  • Sheward DJ; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Thålin C; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden. Electronic address: charlotte.thalin@ki.se.
Lancet Infect Dis ; 24(2): e80-e81, 2024 Feb.
Article en En | MEDLINE | ID: mdl-38190833

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunidad Humoral / Vacuna BNT162 Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2024 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunidad Humoral / Vacuna BNT162 Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2024 Tipo del documento: Article País de afiliación: Suecia